Government Extends Deadline for Pharma Barcodes
New Delhi: The government has extended the deadline to affix barcodes on mono cartons (ointments, eye/ear drops) by pharmaceutical companies to April 2015.
Barcode helps in tracking and tracing origin of drugs, which minimises the chances of genuine medicines being considered spurious, sub-standard or counterfeit.
"Mono cartons are to be treated as part of secondary level packaging and accordingly the requirement of affixing bar-codes on mono-carton as secondary level packaging became effective from June 26, 2014," the Directorate General of Foreign Trade (DGFT) has said in a public notice.
"Now, the effective date of affixing bar-codes on mono-carton as secondary level packaging has been deferred to 1st April, 2015."
The government had asked pharmaceutical firms to build track-and-trace capability for exports using barcode technology at three levels of packaging - primary, secondary and tertiary.
India exports over $10 billion worth of drugs annually.
The government wants to increase that figure manifold in the next few years. There is a big market for generics in the developed world.
Industry experts say that the only way Indian pharma firms can tap global markets is by ensuring quality, and barcoding will help in that.
Primary level packaging is the first-level product packaging such as the bottle, can, jar, tube, that contains the item sold.
Secondary level packaging is a level of packaging that may contain one or more primary packages or a group of primary packages containing a single item.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.